Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


QUOTED. 8 January 2020. Lucien Goffart.

Executive Summary

French company Robocath expects its R-One robotic-assistance platform to make interventional cardiology more efficient and safer for interventionalists. See what company CEO Lucien Goffart said about “momentum in vascular robots” here.

"There is a clear momentum in vascular robots, and so we are clearly attractive [to investors] and feel comfortable about getting enough money to develop the next generation [system].” – Lucien Goffart, CEO, Robocath

Click here for a free trial of Medtech Insight


Related Content





Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts